lobicomics.blogg.se

Stem cell treatment for cancer
Stem cell treatment for cancer








An animal study also found that giving human-induced neural stem cells intravenously to mice was safe and reduced NSCLC tumor cells by seeking and killing them. For example, a 2021 study indicates that mesenchymal stem cells may be able to inhibit NSCLC cells in a lab setting. However, researchers continue to investigate the potential benefits. At present, many experts do not recommend this therapy due to the potential risks, lack of proven benefits, and costs. While a few clinical studies suggest some promise of stem cell therapy in treating NSCLC, more research is necessary due to potential concerns regarding the effectiveness and safety of the therapy. Growing evidence suggests that stem cell therapy may also have some potential to treat other lung conditions, such as chronic obstructive pulmonary disease (COPD). In this article, we look at whether stem cell therapy is a viable treatment for NSCLC along with other new treatment breakthroughs.Ĭurrently, there are limited studies that prove the effectiveness of using stem cell therapy in treating NSCLC, and the majority of these are still under clinical trials. Stem cell therapy is a field of regenerative medicine that utilizes people’s own cells to promote healing, repair damaged tissue, and help boost the immune response to fight off cancer cells and infections. Most lung cancer-related deaths are due to treatment failure and the spreading of cancer cells to distant sites (metastasis).Ĭurrent research proposes that NSCLC’s resistance to treatment and fast progression is due to the presence of specific types of cancer cells, called cancer stem cells (CSCs), which have the ability of normal stem cells, allowing them to divide and proliferate. Lung cancer is one of the most common cancers worldwide and is the leading cause of cancer-related death, representing about 25% of cancer deaths. It occurs when cells that line the lungs grow abnormally. Evidence suggests that roughly 80–85% of lung cancer is NSCLC. Non-small cell lung cancer (NSCLC) is one of the two main types of lung cancer. Experts are looking at the potential of stem cell therapy in developing new therapies aimed at conditions that do not respond well to treatment, such as non-small cell lung cancer.










Stem cell treatment for cancer